Effects of the adenylyl cyclase inhibitor SQ22536 on iloprost-induced vasorelaxation and cyclic AMP elevation in isolated guinea-pig aorta

British Journal of Pharmacology

Volumn 126, Issue 4, 1999, Pages 845-847

  Turcato, Sally ^a   Clapp, Lucie H ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Adenylyl cyclase inhibitor; Cyclic AMP measurement; Guinea pig aorta; Iloprost; SQ22536; Vascular smooth muscle; Vasorelaxation

Indexed keywords

9 (TETRAHYDRO 2 FURYL)ADENINE; CYCLIC AMP; ILOPROST; LYASE INHIBITOR; PHENYLEPHRINE; PROSTACYCLIN DERIVATIVE;

ANIMAL TISSUE; AORTA; AORTA STRIP; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; GUINEA PIG; MALE; NONHUMAN; PRIORITY JOURNAL; VASCULAR ENDOTHELIUM; VASODILATATION;

EID: 0032942393     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0702383     Document Type: Article

References (15)

1. ARMSTRONG, R.A., JONES, R.L., MACDERMOT, J. & WILSON, N.H. (1986). Prostaglandin endoperoxide analogues which are both thromboxane receptor antagonists and prostacyclin mimetics. Br. J. Pharmacol., 87, 543-551.
2. CLAPP, L.H., TURCATO, S., HALL, S.J. & BALOCH, M. (1998). Evidence that Ca2 +-activated K+ channels play a major role in mediating the vascular effects of iloprost and cicaprost. Eur. J. Pharmacol., 356, 215-224.
3. COLEMAN, R.A., SMITH, W.L. & NARUMIYA, S. (1994). International union of pharmacology classification of prostanoid receptors: properties, distribution, and structure of the receptors and their subtypes. Pharmacol. Rev., 46, 205-229.
4. FROLICH, J.C. (1990). Prostacyclin in hypertension. J. Hyperten., S, S73-S78.
5. GRANT, S.M., & GOA, K.L. (1992). Iloprost. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in peripheral vascular disease, myocardial ischaemia and extracorporeal circulation procedures. Drugs, 43, 889-924.
6. HASLAM, R.J., DAVIDSON, M.M. & DESJARDINS, J.V. (1978). Inhibition of adenylate cyclase by adenosine analogues in preparations of broken and intact human platelets. Evidence for the undirectional control of platelet function by cyclic AMP. Biochem.J., 176,83-95.
7. HOLZMANN, S., KUKOVETZ, W.R. & SCHMIDT, K. (1980). Mode of action of coronary arterial relaxation by prostacyclin. J. Cyclic. Nucleoltide. Res., 6, 451-460.
8. JACKSON, W.F., KONIG, A., DAMBACHER, T. & BUSSE, R. (1993). Prostascyclin-induced vasodilation in rabbit heart is mediated by ATP-sensitive potassium channels. Am. J. Physiol., 264, H238H243.
9. OZAKI, H., ABE, A., UEHIGASHI, Y., KINOSHITA, M., HORI, M., MITSUISALTO, M. & KARAKI, H. (1996). Effects of a prostaglandin 12 analog iloprost on cytoplasmic Ca2+ levels and muscle contraction in isolated guinea pig aorta. Jpn. J. Pharmacol., 71, 231-237.
10. RIVA, CM., MORGANROTH, M.L., LJUNGMAN, A.G., SCHOENEICH, S.O., MARKS, R.M., TODD, R.F., WARD, P.A. & BOXER, L.A. (1990). Iloprost inhibits neutrophil-induced lung injury and neutrophil adherence to endothelial monolayers. Am. J. Respir. Cell. Molec. Biol., 3, 301-309.
11. SCHROEDER, G., BECKMANN, R. & SCHILLINGER, E. (1987). Studies on the vasorelaxant effects of and mechanisms of iloprost in isolated preparations. In Prostacyclin and its stable analogue iloprosl. ed. Gryglewski, R.J. & Stock, G. pp. 129-137. Berlin: Springer-Verlag.
12. SCHUBERT, R., SEREBRYAK.OV, V.N., MEWES, H. & HOPP, H.H. (1997). Iloprost dilates rat small arteries: Role of KATP- and KCachannel activation by cAMP-dependent protein kinase. Am. J. Physiol., 272, H1147-H1156.
13. TURCATO, S. & CLAPP, L.H. (1998). Evidence that vasorelaxation induced by Gs coupled receptors is largely independent of cAMP in guinea-pig aorta. J. Mol. Cell. Cardiol., 30, A190.
14. VEGESNA, R.V. & DIAMOND, J. (1986). Elevation of cyclic AMP by prostacyclin is accompanied by relaxation of bovine coronary arteries and contraction of rabbit aortic rings. Ear. J. Pharmacol, 128,25-31.
15. WISE, H. & JONES, R.L. (1996). Focus on prostacyclin and its novel mimetics. Trends. Pharmacol. Sei., 17, 17 -21.